Gilead Hepatitis Elimination Webinar Series: Linkage to Care, Part 4 - Imani Unidad (Indiana, USA)

In the fourth part of the Linkage to Care episode, we focus on the work of Imani Unidad, a non-syringe harm reduction organization that provide support, education, and resources to individuals and communities affected by substance misuse, addiction and related issues.
Join Debra Stanley, Imani Unidad Founder and Chief Executive as she shares the work that her organization has been doing to support the marginalized communities in Indiana and help link them to care.
For more information about Imani Unidad, visit:
Facebook: / imaniunidadinc
For more information about Gilead, visit:
Website: www.gilead.com
Stories@Gilead: stories.gilead...
Twitter: / gileadsciences
LinkedIn: / gileadsc. .
Instagram: / gileadsciences
Facebook: / gileadsciences
About Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
This webinar episode was created and fully funded by Gilead Sciences, Inc. GILEAD, the GILEAD logo, and the & design are trademarks of Gilead Sciences, Inc. © 2023 Gilead Sciences, Inc. All rights reserved.